Rare diseases
Investigational molecules
Locations
Boulevard de la Chantourne, 38700 La Tronche, France
CHU Grenoble Alpes in La Tronche, France specialises in clinical trials of conditions such as Acute lymphocytic leukaemia, Plasma cell myeloma, Arteriosclerosis, Breast cancer, and other specialisations. This site conducts important research.
The CHU Grenoble Alpes pediatric oncology unit is conducting research on acute lymphoblastic leukemia in children and adolescents, testing new dosing schedules of pegaspargase to improve drug exposure and reduce side effects.
With 177 investigators participating, the study aims to enhance survival rates and quality of life for young patients while providing valuable data on pharmacokinetics and tolerance.
Researchers at CHU Grenoble Alpes are evaluating the combination of olomorasib with immune checkpoint inhibitors for KRAS G12C‑mutant non‑small cell lung cancer, seeking to boost treatment efficacy and monitor safety in patients with unresectable disease.
This multicenter, open‑label trial integrates detailed immunophenotypic profiling to identify which patients benefit most, aiming to expand therapeutic options for a challenging cancer subtype.
More sites in La TroncheFrance
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
FranceCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
FranceTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
FranceA study comparing one month versus one year of aspirin and clopidogrel treatment in patients with chronic limb-threatening ischemia after below-the-knee vascular therapy.
FranceA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
FranceFranceA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
FranceStudy of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia
FranceStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
FranceStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy on Dexamethasone for Patients with Advanced Relapsed or Refractory Multiple Myeloma
FranceStudy on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
